Peanut flavone glycosyltransferase, coding sequence and preparation and detection applications thereof

By using peanut flavonoid glycosyltransferase and a fractional hydrolysis method, the problem of accurately quantifying the form of naringenin in peanut roots was solved, achieving high-precision detection results.

CN123063371APending Publication Date: 2026-11-10LIAONING INST OF SCI & TECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611596065.6
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-10-15
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing technologies are insufficient to effectively distinguish and quantify the different forms of naringenin in peanut roots, especially at low concentrations or when there are large differences in content. Direct detection is prone to concentration-related biases, and hydrolysis methods cannot accurately trace the source of the compound.

Method used

Peanut flavonoid glycosyltransferase was used to transfer glucose or labeled glucose to the 7-hydroxyl group of naringenin, followed by fractional hydrolysis with β-D-glucosidase and α-L-rhamnosidase. Labeled glycosides were identified by liquid chromatography-tandem mass spectrometry, and the contents of the three existing forms were calculated by combining the recovery correction factor and the hydrolysis release rate.

Benefits of technology

Accurate quantification of naringenin, naringenin-7-O-β-D-glucoside, and naringenin in peanut roots was achieved with a comprehensive quantification error of less than 4.3%, a correct attribution rate of 96.7%, and an average spiked recovery rate of 99.1%, reducing the impact of matrix response and treatment loss.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123063371A_ABST
    Figure CN123063371A_ABST
Patent Text Reader

Abstract

This invention discloses a method and kit for detecting three forms of naringenin in peanut roots. The root extract is divided into three equal portions: reaction solution A, B, and C. Solution A is not hydrolyzed; solution B is hydrolyzed using β-D-glucosidase; and solution C is hydrolyzed sequentially using α-L-rhamnosidase and β-D-glucosidase. After hydrolysis, the enzymes are removed by ultrafiltration. The three reaction solutions are then adjusted to the same conditions, and arachidonic acid transferase and UDP-[U-] 13 C6] Glucose is used to convert naringenin, either naturally occurring or hydrolyzed, into isotopically labeled glycosides. The labeled glycosides are determined using liquid chromatography-tandem mass spectrometry. Based on the determination results of A, the correction difference between B and A, and the correction difference between C and B, the contents of free naringenin, naringenin-7-O-β-D-glucoside, and naringenin are determined, respectively. This invention can reduce cross-attribution between different forms and matrix response differences, improving the selectivity, accuracy, and reliability of detection in complex root samples.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention belongs to the fields of enzyme engineering and bioengineering technology, specifically relating to a peanut flavonoid glycosyltransferase, a polynucleotide encoding the glycosyltransferase, and the preparation of the glycosyltransferase, as well as the application of the glycosyltransferase in the detection of different forms of naringenin in peanut root samples and a detection kit. Background Technology

[0002] Flavonoids are an important component of peanut root secondary metabolites, and their content and forms vary with salt stress, mineral supply, and root physiological state. Naringenin can exist in free form or further form naringenin-7-O-β-D-glucoside and naringenin. Different forms differ in solubility, stability, migration ability, and bioavailability. Measuring only total naringenin or a single glycoside in a sample is insufficient to fully reflect the composition and transformation of naringenin in peanut roots.

[0003] Currently, naringenin and its glycosides in plant samples are typically detected using liquid chromatography, liquid chromatography-tandem mass spectrometry, or high-resolution mass spectrometry. Direct detection requires establishing quantitative relationships for each compound separately, but the extraction recoveries, ionization efficiencies, and matrix responses of different compounds are not entirely identical. Peanut root extracts also contain various phenolic acids, flavonoids, and their isomers, which can easily cause ion inhibition or signal overlap. Especially when the analyte concentration is low or the content of different speciations varies significantly, direct external standard quantification is prone to concentration-related biases and makes it difficult to determine whether the detection signal originates from the original glycosides in the sample or products formed during processing.

[0004] Acid hydrolysis or mixed enzymatic hydrolysis can convert some flavonoid glycosides into aglycones, but usually only the total amount before and after hydrolysis is obtained. If two hydrolytic enzymes are added simultaneously, both monoglucoside and rutin can release naringenin, and the resulting naringenin signal is difficult to trace to the specific binding form. A single hydrolysis step cannot simultaneously distinguish between free naringenin, naringenin monoglucoside, and naringenin rutin. Furthermore, residual hydrolytic enzymes may continue to act on the substrate or interfere with subsequent enzymatic reactions, making it difficult to maintain consistent reaction conditions and detection responses for different treatment solutions.

[0005] Although using stable isotope internal standards can compensate for fluctuations caused by sample introduction and instrument response, the addition of conventional isotope internal standards in advance cannot represent the amount of naringenin released after hydrolysis of different glycosides, nor can it resolve the issue of source attribution among the three existing forms. Therefore, it is necessary to establish a detection method that can release naringenin step by step according to the glycoside structure and convert each stage of naringenin release into a unified product with an independent quality signal to improve the ability to identify and quantify different naringenin forms in complex peanut root samples. Summary of the Invention

[0006] According to a first aspect of this application, a peanut flavonoid glycosyltransferase is provided, the amino acid sequence of which is shown in SEQ ID NO:1, and is prefixed with UDP-glucose or UDP-[U- 13 [C6] Glucose is used as a glycosyl donor, and the glucose or [U- 13 [C6] Glucose is transferred to the 7-hydroxyl group of naringenin.

[0007] According to a second aspect of this application, a polynucleotide encoding a peanut flavonoid glycosyltransferase is provided, the nucleotide sequence of which is shown in SEQ ID NO:2, and the peanut flavonoid glycosyltransferase it encodes has the function of transferring glucose or [U- 13 Catalytic activity of C6] glucose transfer to the 7-hydroxyl group of naringenin.

[0008] According to a third aspect of this application, a method for preparing a peanut flavonoid glycosyltransferase having the amino acid sequence shown in SEQ ID NO:1 is provided, comprising introducing a recombinant expression vector containing the nucleotide sequence shown in SEQ ID NO:2 into a host cell, culturing the host cell and inducing expression, collecting the cells or culture, purifying them by affinity chromatography, and optionally further purifying them by molecular sieve chromatography.

[0009] According to the fourth aspect of this application, a method for detecting naringenin, naringenin-7-O-β-D-glucoside, and naringenin in peanut root samples is provided, comprising: dividing peanut root extract into three equal portions: reaction solution A, reaction solution B, and reaction solution C; reaction solution A is not hydrolyzed, reaction solution B is hydrolyzed using β-D-glucosidase, and reaction solution C is hydrolyzed sequentially using α-L-rhamnosidase and β-D-glucosidase; after terminating the hydrolysis and removing the hydrolytic enzymes, the three reaction solutions are adjusted to the same reaction conditions, and arachidonic acid transferase and UDP-[U-]acetyltransferase with the amino acid sequence shown in SEQ ID NO:1 are added respectively. 13 C6] glucose, which converts naringenin in it into naringenin-7-O-[U- 13 C6] Glucoside; The amount of the labeled glycoside in the three reaction solutions was determined by liquid chromatography-tandem mass spectrometry. Based on the determination results of reaction solution A, the correction difference between reaction solution B and reaction solution A, and the correction difference between reaction solution C and reaction solution B, the contents of free naringenin, naringenin-7-O-β-D-glucoside and naringenin were determined respectively.

[0010] Further, in reaction solution B, β-D-glucosidase hydrolyzes naringenin-7-O-β-D-glucosinolate to release naringenin; in reaction solution C, α-L-rhamnosidase first hydrolyzes naringenin to naringenin-7-O-β-D-glucosinolate, and then β-D-glucosidase hydrolyzes it to release naringenin; after hydrolysis, an ultrafiltration membrane with a molecular weight cutoff of 3 kDa to 30 kDa is used to remove the hydrolytic enzymes, the ultrafiltrate is collected, and the pH, ionic strength, and volume of reaction solutions A, B, and C are adjusted so that the three reaction solutions have the same enzymatic reaction conditions before the addition of the peanut flavonoid glycosyltransferase.

[0011] Furthermore, the naringenin-7-O-[U- 13 [C6] glucoside has a molecular weight difference of 6.0201 Da compared to naringenin-7-O-β-D-glucoside; using naringenin-7-O-β-D-glucoside and naringenin-7-O-[U- 13 At least one of the C6 glucosides is used as a quantitative reference, and the labeled glycoside is identified based on at least two of the chromatographic retention time, the mass of the parent ion, and the mass of the daughter ion.

[0012] Furthermore, the aglycone molar equivalent of free naringenin was obtained by the following method: naringenin-7-O-[U- 13 The molar amount of C6] glucosinolate was divided by the comprehensive recovery correction coefficient of reaction solution A, and then divided by the mass of peanut root sample. The aglycone molar equivalent of naringenin-7-O-β-D-glucoside was obtained by dividing the measured molar amount of the labeled glycoside in reaction solution B and reaction solution A by the corresponding comprehensive recovery correction coefficient, subtracting the corrected molar amount of reaction solution A from the corrected molar amount of reaction solution B, and then dividing the difference by the hydrolysis release rate of naringenin-7-O-β-D-glucoside and the sample mass. The molar equivalent of naringin was obtained by dividing the measured molar amount of the labeled glycoside in reaction solution C and reaction solution B by the corresponding comprehensive recovery correction coefficient, subtracting the corrected molar amount of reaction solution B from the corrected molar amount of reaction solution C, and then dividing the difference by the hydrolysis release rate of naringin and the sample mass.

[0013] The contents of free naringenin, naringenin-7-O-β-D-glucoside, and naringenin are calculated according to the following formulas: ; ; ; In the formula, , and The aglycone molar equivalents of free naringenin, naringenin-7-O-β-D-glucoside and naringenin respectively; , and Naringenin-7-O-[U-] in reaction solutions A, B, and C, respectively. 13 The molar amount of C6] glucoside was determined. , and These are the comprehensive recovery correction coefficients for the corresponding reaction solutions; The hydrolysis release rate of naringenin-7-O-β-D-glucoside; The hydrolysis release rate of rutin in naringin from naringin peel; The quality of peanut root samples.

[0014] According to a fifth aspect of this application, a kit is provided for detecting the speciation of flavonoids in peanut root samples, comprising arachidonic acid transferase with the amino acid sequence shown in SEQ ID NO:1, UDP-[U- 13 [C6] Glucose, β-D-glucosidase, α-L-rhamnosidase, glycosyltransferase reaction buffer and hydrolysis reaction buffer.

[0015] Furthermore, it also includes naringenin, naringenin-7-O-β-D-glucoside, naringenin, and naringenin-7-O-[U- 13 The C6] glucosidase contains at least one quantitative reference, and an ultrafiltration unit with a molecular weight cutoff of 3kDa to 30kDa; the β-D-glucosidase and α-L-rhamnosidase are packaged separately.

[0016] According to a sixth aspect of this application, the use of an arachidonic transferase with the amino acid sequence shown in SEQ ID NO:1 in the preparation of a detection reagent or kit for distinguishing and detecting free naringenin, naringenin-7-O-β-D-glucoside, and naringenin in peanut root samples is provided, wherein the arachidonic transferase is in the form of UDP-[U- 13 [C6] Glucose serves as a sugar donor, converting naringenin, either pre-existing or released during hydrolysis, into naringenin-7-O-[U-] 13 C6] glucoside.

[0017] The beneficial effects of this invention are as follows: 1. This invention divides peanut root extract into three equal parts: reaction solution A, reaction solution B, and reaction solution C. The release results are obtained through non-hydrolysis, single-enzyme hydrolysis, and sequential double-enzyme hydrolysis. Reaction solution A reflects the original free naringenin in the sample; the increased signal in reaction solution B compared to reaction solution A reflects the naringenin released by the hydrolysis of naringenin-7-O-β-D-glucoside; and the increased signal in reaction solution C compared to reaction solution B reflects the further hydrolysis of naringenin by naringenin rutin. Therefore, it is possible to identify three different forms of naringenin in the same sample.

[0018] 2. In this invention, an ultrafiltration unit is used to remove α-L-rhamnosidase and β-D-glucosidase after hydrolysis, and the pH, ionic strength, and volume of the three reaction solutions are adjusted to the same conditions. This treatment can terminate hydrolysis in a timely manner, reduce the impact of residual hydrolytic enzymes on subsequent glycosyltransferase reactions, and reduce the differences in reaction environment caused by different hydrolysis treatments, making the labeling signals generated by the three reaction solutions more comparable.

[0019] 3. This invention utilizes the arachidonic transferase shown in SEQ ID NO:1, with UDP-[U- 13 C6] Glucose serves as a glycosyl donor, converting naringenin, either pre-existing or hydrolyzed, in the sample into naringenin-7-O-[U- 13 [C6] glucoside. This labeled product has a mass difference of 6.0201 Da from natural naringenin-7-O-β-D-glucoside, and can be identified through an independent mass spectrometry channel, reducing the interference of the original glycoside in the sample on the signal of the newly generated product, and enabling quantification of naringenin from different sources using the same labeled product.

[0020] 4. This invention combines the comprehensive recovery correction coefficient of each reaction solution with the hydrolysis release rate of the corresponding glycosides to calculate the difference in the determination results of the three reaction solutions. The test results show that the comprehensive quantitative error of the complete detection method is 4.3%, the correct attribution rate of the three existing forms is 96.7%, the average spiked recovery rate is 99.1%, and the coefficient of variation is 2.4%, indicating that this method can reduce the influence of matrix response, processing loss, and differences in analyte concentration on the results.

[0021] 5. The arachidonic acid transferase, stable isotopic glycosyl donor, two hydrolases, reaction buffer and ultrafiltration components used in this invention can be packaged separately to form a detection kit, which facilitates the completion of graded hydrolysis, enzyme removal, enzymatic labeling and quantitative detection under uniform conditions. It is suitable for the detection of different forms of naringenin in peanut root samples and for salt stress response studies. Attached Figure Description

[0022] The invention will now be described in more detail with reference to embodiments and the accompanying drawings. Figure 1Electrophoresis image of PCR amplification of the target gene fragment LOC112754776.

[0023] Figure 2 The structural map of the pET-His6-SUMO-LOC112754776 recombinant expression plasmid.

[0024] Figure 3 This is an SDS-PAGE electrophoresis image of the protein encoded by LOC112754776 after induction expression, affinity purification, enzyme digestion, and molecular exclusion purification.

[0025] Figure 4 The results show the chromatographic and secondary mass spectrometry identification, stable isotope mass shift, Michaelis kinetics, and conversion rates of different substrates for the products catalyzed by peanut flavonoid glycosyltransferase.

[0026] Figure 5 This is a flowchart illustrating the reaction process of β-glucosidase hydrolyzing naringenin monoglucoside.

[0027] Figure 6 This is a diagram showing the reaction process of α-L-rhamnosidase and β-glucosidase sequentially hydrolyzing naringin.

[0028] Figure 7 The figure shows a comparison of the substrate selectivity of different glycosidases and the residual activity of glycosidases after ultrafiltration treatment with different molecular weight cutoffs, as well as the recovery rate of naringenin.

[0029] Figure 8 The figure shows the calibration relationship, spiked recovery, matrix effect, precision, stability, and consistency between theoretical and actual values ​​for the detection of free naringenin, naringenin-7-O-β-D-glucoside, and naringenin.

[0030] Figure 9 A comparative graph showing the overall quantitative error, correct morphology attribution rate and cross-attribution rate, spiked recovery rate, data dispersion, and relative deviation at different concentration levels obtained from different detection schemes.

[0031] Figure 10 This is a diagram illustrating the constant-temperature soaking process for peanut seeds.

[0032] Figure 11 This diagram illustrates the process of peanut seed germination, seedling transplantation, and pre-treatment cultivation.

[0033] Figure 12 The growth status of peanut seedlings at 12 h, 24 h and 36 h is shown for control, salt treatment, calcium treatment and combined salt and calcium treatment.

[0034] Figure 13 The growth status of peanut seedlings at 48 h, 60 h and 72 h is shown for control, salt treatment, calcium treatment and combined salt and calcium treatment.

[0035] Figure 14 Principal component analysis diagram of flavonoid metabolites in peanut roots from different treatment groups.

[0036] Figure 15 K-means cluster analysis diagram of differential metabolites in peanut roots from different treatment groups.

[0037] Figure 16 A diagram showing the enrichment of KEGG pathways for differentially expressed genes in peanut roots from different treatment groups.

[0038] Figure 17 Cluster analysis diagram of the normalized relative abundance of flavonoid metabolites in peanut roots of different treatment groups. Detailed Implementation

[0039] The technical solutions of the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present invention, and not all embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without creative effort are within the scope of protection of the present invention.

[0040] Unless otherwise specified, the purity of naringenin, naringenin-7-O-β-D-glucoside, and naringenin standards shall not be less than 98%; UDP-glucose shall be obtained using analytical grade reagents, and UDP-[U- 13 The isotopic abundance of glucose [C6] was not less than 99 atom%. β-D-glucosidase and α-L-rhamnosidase were prepared using commercially available enzyme formulations screened for substrate specificity. Methanol, acetonitrile, and formic acid were all of chromatographic purity, and ultrapure water was used in the experiments.

[0041] The term "arachidonic transferase" as used in this application refers to a protein with the amino acid sequence shown in SEQ ID NO:1; the nucleotide sequence encoding this protein is shown in SEQ ID NO:2. The stop codon at the end of SEQ ID NO:2 does not participate in protein translation.

[0042] Liquid chromatography was performed using a C18 reversed-phase column with dimensions of 2.1 mm × 100 mm and a packing particle size of 1.7–3 μm. Mobile phase A consisted of water containing 0.1% formic acid, and mobile phase B consisted of acetonitrile. The flow rate was 0.30 mL / min, the column temperature was 35 °C, and the injection volume was 2 μL. The gradient elution program was as follows: 0–1 min, 10% mobile phase B; 1–8 min, mobile phase B linearly increased from 10% to 45%; 8–10 min, mobile phase B increased to 95%; 10–12 min, maintained at 95%; 12.1–15 min, restored to 10% and the column equilibrated.

[0043] Mass spectrometry was performed in electrospray ionization (ESI) negative ion mode and multiple reaction monitoring (MRM) mode. Naringenin was identified as the precursor ion with a mass-to-charge ratio (M / C) of 271.1; naringenin-7-O-β-D-glucoside was identified as the precursor ion with a M / C of 433.1 and the major product ion with a M / C of 271.1; naringenin was identified as the precursor ion with a M / C of 579.2 and the major product ion with a M / C of 271.1; naringenin-7-O-[U- 13 C6] glucoside was used with a mass-to-charge ratio of 439.1 as the parent ion and a mass-to-charge ratio of 271.1 as the major product ion. Collision energy, ion source temperature, gas flow rate, and residence time were optimized based on the mass spectrometer used.

[0044] Example 1: Preparation of arachidonic acid transferase and preparation of labeled product 1. Amplification of the target fragment LOC112754776 Total RNA was extracted from peanut root tissue and cDNA was obtained by reverse transcription. Using the obtained cDNA as a template, specific amplification primers were designed according to the nucleotide sequence shown in SEQ ID NO:2. BamHI and XhoI restriction sites were introduced at the 5′ ends of the forward and reverse primers, respectively, to amplify the 1479 bp coding fragment of LOC112754776.

[0045] PCR amplification was performed using high-fidelity DNA polymerase. The amplification program was as follows: 98℃ pre-denaturation for 3 min; 98℃ denaturation for 10 s, 60℃ annealing for 15 s, 72℃ extension for 45 s, for a total of 35 cycles; 72℃ extension for 5 min. The amplification products were analyzed by 1.0% agarose gel electrophoresis, and the results are as follows. Figure 1 As shown.

[0046] Figure 1 In the diagram, M represents the DNA molecular weight standard; lanes 1-3 represent three parallel amplification products of LOC112754776; and N is a template-free negative control. Clear and consistent target bands appeared at approximately 1479 bp in lanes 1-3, with no obvious non-specific amplification bands observed. No corresponding bands appeared in the negative control lanes, indicating that the LOC112754776 target fragment of expected length and good specificity was obtained.

[0047] 2. Construction of recombinant expression vectors The 1479 bp target fragment was recovered, and both the target fragment and the pET-His6-SUMO expression vector were double-digested with BamHI and XhoI, respectively. After ligation with ligase, the fragments were transformed into E. coli cloning hosts. Positive clones were selected for colony PCR and sequencing verification. The recombinant plasmid with the correct sequence and insertion orientation was selected and named pET-His6-SUMO-LOC112754776.

[0048] Recombinant vector map as follows Figure 2 As shown. Figure 2 This is a map of the recombinant expression plasmid pET-His6-SUMO-LOC112754776. The plasmid is 7118 bp in length, with the expression cassette arranged clockwise starting from the top 0 site. The T7 promoter / lacO is located approximately 177–235 bp, the His6-SUMO tag is located approximately 300–618 bp, and the SUMO protease cleavage site is located approximately 619–639 bp. The target fragment LOC112754776 is located approximately 640–2118 bp, with a length of 1479 bp. This target fragment is located between the BamHI and XhoI cleavage sites, with its 5′ end defined by BamHI 632 and its 3′ end defined by XhoI 2124, maintaining the same reading frame as the upstream His6-SUMO tag and SUMO protease cleavage site. The downstream T7 terminator is located approximately 2150–2230 bp. The vector backbone contains approximately 3000–3815 bp of kanR, approximately 4400–5200 bp of pBR322 ori, and approximately 5500–6580 bp of lacI. Figure 2 This indicates that the target gene, after double enzyme digestion and directional insertion into the T7 expression cassette, can achieve His6-SUMO fusion expression, supporting resistance selection, plasmid replication, and induction regulation. The full-length recombinant plasmid shown in the figure is 7118 bp. The constructed expression cassette is arranged in the order of T7 promoter / lacO—His6-SUMO—SUMO protease cleavage site—LOC112754776—T7 terminator, which can express the His6-SUMO fusion protein under controlled induction conditions, and the fusion tag can be removed by SUMO protease after purification.

[0049] Figure 2 The vector also includes the kanamycin resistance gene kanR, the pBR322 origin of replication, and the lacI regulatory gene. KanR is used for resistance selection of positive transformants, pBR322 ori is used to maintain the replication of the recombinant plasmid in *E. coli*, and lacI encodes a repressor protein used to reduce background expression in the uninduced state.

[0050] 3. Induced expression of recombinant proteins The correctly sequenced pET-His6-SUMO-LOC112754776 recombinant plasmid was transformed into *E. coli* BL21(DE3) competent cells. Single colonies were picked and inoculated into kanamycin-containing medium and cultured at 37°C and 180 r / min until OD600. 600 The concentration was 0.6–0.8, and IPTG was added to a final concentration of 0.20 mmol / L. The mixture was then inducible at 16°C for another 16 h.

[0051] After cultivation, the bacterial cells were collected by centrifugation at 4°C and 6000×g for 10 min. The bacterial cells were resuspended at a ratio of 8–10 mL of lysis buffer per gram of wet bacterial cells. The lysis buffer contained 20 mmol / L Tris-HCl, 150 mmol / L NaCl, and 10 mmol / L imidazole, with a pH of 7.5. The bacterial cells were then sonicated in an ice bath and centrifuged at 4°C and 12000×g for 30 min. The supernatant and precipitate were collected separately.

[0052] 4. Purification of recombinant proteins The supernatant from bacterial cell lysis was added to a Ni-NTA affinity chromatography column pre-equilibrated with lysis buffer, and the flow-through was collected. The column was washed successively with wash buffers containing 20 mmol / L imidazole and 40 mmol / L imidazole to remove non-specifically bound proteins; subsequently, the His6-SUMO-LOC112754776 fusion protein was eluted with elution buffer containing 250 mmol / L imidazole.

[0053] The obtained eluent was dialyzed to reduce the imidazole concentration, and SUMO protease was added. The mixture was digested at 4°C for 12–16 h to separate the His6-SUMO tag from the glycosyltransferase encoded by LOC112754776. The digested protein was then passed through a Ni-NTA affinity chromatography column again. The His6-SUMO tag, the incompletely digested fusion protein, and the SUMO protease with the affinity tag bound to the chromatography medium, while the untagged target glycosyltransferase was mainly present in the flow-through.

[0054] The secondary Ni-NTA flow-through was collected and subjected to gel filtration chromatography. The gel filtration buffer contained 20 mmol / L Tris-HCl and 150 mmol / L NaCl, with a pH of 7.5. The target protein peak was collected and concentrated to obtain purified arachidonic transferase.

[0055] 5. Results of recombinant protein expression and purification Each expressed and purified component was analyzed by SDS-PAGE, and the results are as follows: Figure 3 As shown. Figure 3 In the table, M represents the molecular weight standard of protein; U represents the total protein of uninduced bacterial cells; I represents the total protein of IPTG-induced bacterial cells; S represents the supernatant of bacterial cell lysis; P represents the bacterial cell lysis precipitate; FT represents the first Ni-NTA flow-through buffer; W20 and W40 represent 20 mmol / L and 40 mmol / L imidazole washing buffer, respectively; E250 represents 250 mmol / L imidazole elution buffer; C represents the SUMO protease digestion product; N represents the second Ni-NTA flow-through buffer; and SEC represents the gel filtration purified product.

[0056] Compared to the uninduced group U, the induced group I showed a significantly enhanced protein band at approximately 67.4 kDa, corresponding to the His6-SUMO-LOC112754776 fusion protein. The intensity of this band in the lysis supernatant S was higher than that in the precipitate P, indicating that the fusion protein was primarily expressed in a soluble form. Only a small amount of the target band was observed in the first Ni-NTA flow-through buffer FT and wash buffers W20 and W40, while the approximately 67.4 kDa band was significantly enriched in the 250 mmol / L imidazole elution fraction E250, indicating that the fusion protein could effectively bind to the Ni-NTA chromatography medium and be eluted by a high concentration of imidazole.

[0057] After treatment with SUMO protease, the approximately 67.4 kDa fusion protein band in enzyme digestion fraction C was significantly weakened, while a target glycosyltransferase band of approximately 55.2 kDa and a His6-SUMO tag band of approximately 12.2 kDa appeared, indicating that the fusion tag was effectively cleaved. In the second Ni-NTA flow-through fraction N, the approximately 55.2 kDa target protein band predominated, while the approximately 12.2 kDa tag band was essentially removed. After purification by gel filtration, the SEC lane mainly showed a single protein band of approximately 55.2 kDa, indicating that a high-purity recombinant arachidonic transferase was obtained.

[0058] Gel grayscale analysis, BCA protein quantification, and peptide mass spectrometry identification were performed on the SEC components. The results are shown in Table 1. Figure 1 , Figure 2 and Figure 3 .

[0059] Table 1. Identification of recombinant proteins or related basic data

[0060] The results showed that the apparent molecular weight of the prepared protein was consistent with the theoretical molecular weight of the protein encoded by LOC112754776; a total of 19 specific peptides were detected by peptide mass spectrometry, and the sequence coverage of the target protein reached 68.9%, further proving that the obtained protein was an arachidonic transferase encoded by LOC112754776.

[0061] 6. Recombinant protein activity and preparation of isotope-labeled products A 200 μL enzymatic reaction system was prepared, containing 50 mmol / L Tris-HCl, 5 mmol / L MgCl2, 100 μmol / L naringenin, 1 mmol / L glycosyl donor, and 0.1 mg / mL of the purified arachidonic acid transferase, with a pH of 7.5. Based on a final concentration of 0.1 mg / mL, 20 μg of the purified enzyme was added to each 200 μL reaction system.

[0062] When UDP-glucose is used as a glycosyl donor, it is used to prepare non-isotope labeled products; when UDP-[U- 13 [C6] Glucose was used as a glycosyl donor to prepare isotope-labeled products. The reaction system was reacted at 30℃ for 60 min, and the reaction was terminated by adding 200 μL of methanol. After mixing, the mixture was centrifuged, and the supernatant was collected for detection by liquid chromatography-tandem mass spectrometry.

[0063] When UDP-glucose was used as the donor, a signal of m / z 433.1→271.1 corresponding to naringenin-7-O-glucoside was detected, where m / z represents the mass-to-charge ratio of the ion, i.e., the ratio of the ion's mass to its charge number; the arrows indicate the monitoring and conversion relationship between the parent ion and the daughter ion in tandem mass spectrometry. For example, m / z 433.1→271.1 indicates that the parent ion with a mass-to-charge ratio of 433.1 is fragmented by collision to form a daughter ion with a mass-to-charge ratio of 271.1. This ion pair is used for the qualitative and quantitative detection of the target product; when UDP-[U- 13 When glucose was used as the donor, a signal of m / z 439.1→271.1 was detected corresponding to the isotope-labeled naringenin-7-O-glucoside. The precursor ion mass difference between the labeled and unlabeled products was 6.0201 Da, which is consistent with the 6... 13 C atoms replace 6 12 The theoretical mass difference generated by the C atom is consistent with this. No corresponding product signal was detected in the negative control (without enzyme or glycosyl donor), indicating that the recombinant arachidonic acid transferase can catalyze the transfer of glucose groups to the 7-OH site of naringenin and can prepare the corresponding product. 13 C6 isotope-labeled glycoside products.

[0064] Example 2: Detection of three naringenin forms in peanut roots Take freeze-dried peanut root samples, pulverize and mix them thoroughly. Accurately weigh 200 mg of the mixture and add it to 2.00 mL of 70% (v / v) methanol aqueous solution. Extract by sonication for 30 min, centrifuge and collect the supernatant. Extract the residue again with the same solvent and combine the supernatants. Remove methanol at a temperature not exceeding 30℃, reconstitute with water and bring the volume to 2.00 mL to obtain peanut root extract. Take three 0.50 mL portions of this extract, labeled as reaction solution A, reaction solution B, and reaction solution C, respectively. Each extract corresponds to 50 mg of freeze-dried root sample.

[0065] Add 0.10 mL of acetate buffer (pH 5.0) to each of the three reaction solutions. Specifically, add α-L-rhamnosidase for screening rutin in naringin to reaction solution C, bringing the final concentration in reaction solution C to 2.0 U / mL. Add an equal volume of acetate buffer without the enzyme to reaction solutions A and B. Incubate all three reaction solutions at 37°C for 45 min. Then, add 0.10 mL of β-D-glucosidase solution to reaction solutions B and C, bringing the final concentration of β-D-glucosidase in the corresponding reaction solutions to 2.0 U / mL. Add an equal volume of buffer without the enzyme to reaction solution A, and continue the reaction at 37°C for 60 min. Reaction solution B releases naringenin from the original naringenin-7-O-β-D-glucoside through treatment with β-D-glucosidase; reaction solution C first removes the terminal rhamnose from naringenin, and then releases naringenin from the formed naringenin-7-O-β-D-glucoside.

[0066] After the reaction was completed, the three reaction solutions were immediately placed in an ice bath and transferred to an ultrafiltration unit with a molecular weight cutoff of 10 kDa. They were then centrifuged and ultrafiltered at 4°C to remove α-L-rhamnosidase and β-D-glucosidase and terminate the hydrolysis reaction. 0.20 mL of each filtrate was added to twice the concentration of glycosyltransferase reaction mixture, so that the final reaction system contained 50 mmol / L Tris-HCl, 5 mmol / L MgCl2, and 1 mmol / L UDP-[U- 13 [C6] Glucose and 0.1 mg / mL of the arachidonic transferase prepared in Example 1, pH 7.5. After reacting at 30°C for 60 min, an equal volume of methanol was added to terminate the reaction, and the supernatant was collected by centrifugation. The mass of each lyophilized root sample corresponding to the filtrate used for labeling reaction was 0.010 g.

[0067] Following the C18 column, elution gradient, and negative ion multiple reaction monitoring conditions described above in the specific implementation method, naringenin-7-O-[U-] in reaction solutions A, B, and C were obtained, respectively. 13 The peak area of ​​[C6] glucoside was determined, and its molar amount was calculated using a standard curve of labeled glycoside references. The substrate selectivity, intermediate product formation, and hydrolysis release rate of the two hydrolytic enzymes were examined using standard reaction solutions containing unhydrolyzed naringenin, naringenin-7-O-β-D-glucoside alone, and naringenin alone.

[0068] Separately, root powder from the same batch was collected, and a known molar amount of naringenin was added to each sample before extraction. The increment of labeled product before and after spiking was determined according to the processing procedures of reaction solutions A, B, and C. Considering the total influence of each step of sample extraction, aliquoting, ultrafiltration, and enzymatic labeling, the comprehensive recovery correction coefficients for the three reaction solutions were calculated. , and The hydrolytic release rates of quercetin-7-O-β-D-glucoside were determined using independently spiked samples of monosaccharide glycoside and naringin. and the effective hydrolysis release rate of naringin in reaction solution C relative to reaction solution B. After confirming that the direct hydrolysis of naringin by reaction solution B is negligible, and that reaction solutions B and C have the same hydrolytic response to the original monosaccharide glycosides, the following formula is used for calculation: ; ; ; In the formula, , and The molar equivalents of free naringenin, naringenin-7-O-β-D-glucoside and naringenin, in order, are in nmol / g dry weight. , and The labeled naringenin-7-O-[U-] was measured in reaction solutions A, B, and C. 13 [C6] glucoside molar amount, in nmol; The weight of the lyophilized root system corresponding to each labeled reaction solution is 0.010 g in this example; , , , and All are dimensionless coefficients, specifically, , and These are the comprehensive recovery correction coefficients for the corresponding reaction solutions; The hydrolysis release rate of naringenin-7-O-β-D-glucoside; The hydrolysis release rate of rutin from naringenin in naringenin is given.

[0069] For reaction solution A, reaction solution B, or reaction solution C, the comprehensive recovery correction factor is calculated according to the following formula: ; In the formula, It can be A, B, or C; This refers to the molar amount of labeled glycoside measured in the corresponding spiked reaction solution; This corresponds to the molar amount of labeled glycoside measured in the unspiked reaction solution;

[0070] Hydrolytic release rate of naringenin-7-O-β-D-glucoside The effective hydrolytic release rate of naringenin was determined based on the ratio of the corrected molar increase in reaction solution B relative to the spiked molar amount in the independently spiked sample of naringenin-7-O-β-D-glucoside. The value was determined based on the ratio of the corrected molar increase in reaction solution C relative to the spiked molar amount in the independently spiked sample of naringin.

[0071] Example 3: Assembly of the detection kit and detection of root samples The arachidonic transferase obtained in Example 1, UDP-[U- 13 C6] Glucose, β-D-glucosidase, α-L-rhamnosidase, glycosyltransferase reaction buffer, and hydrolysis reaction buffer are separately packaged to form a kit for detecting the presence of flavonoids in peanut roots. β-D-glucosidase and α-L-rhamnosidase are individually packaged. The kit also includes naringenin, naringenin-7-O-β-D-glucosinolate, naringenin-7-O-[U- 13 At least one of the C6 glucosides was used as a quantitative reference, and an ultrafiltration module with a molecular weight cutoff of 10 kDa was used.

[0072] Peanut root samples were collected from the control, salt stress, and combined salt stress and exogenous calcium treatments, with sampling times of 6 h and 48 h for each treatment. Extracts were prepared from each sample, and the three-stage paired hydrolysis, ultrafiltration, isotope enzymatic labeling, and liquid chromatography-tandem mass spectrometry (LC-MS / MS) were performed according to the method in Example 2. Each treatment was replicated independently, and the same final analyte was repeatedly injected. The peak area of ​​the labeled glycoside, the molar equivalent of the standard curve, and the overall recovery correction factor were recorded for each of the three reaction solutions. The molar equivalents of the three aglycones and their respective proportions in the total amount of the three aglycones were calculated.

[0073] The root samples in this embodiment were used to verify the applicability of the test kit to different treated samples, and were carried out independently from the seedling dynamic treatment experiment described in Test Example 4.

[0074] Comparative Example 1: Direct Liquid Chromatography-Tandem Mass Spectrometry Detection Peanut root extract from the same batch as in Example 2 was used, but without fractional hydrolysis or isotope enzymatic labeling, and injected under the same liquid chromatography conditions. Quantitative curves were established using unlabeled naringenin, naringenin-7-O-β-D-glucoside, and naringenin standards to determine the content of the three compounds in the sample. Solvent-matched and matrix-matched standard curves were also established for each standard, and pre-extraction and post-extraction spikes were performed to calculate the recoveries and matrix effects of the three compounds. The results were compared with those from Example 2 expressed in aglycone molar equivalents.

[0075] Comparative Example 2: Detection of unlabeled UDP-glucose Take peanut root extract from the same batch as in Example 2, and keep the pairing method, hydrolysis conditions, ultrafiltration operation, and glycosyl transfer reaction conditions of reaction solutions A, B, and C the same, except for UDP-[U- 13 C6] Glucose was replaced equimolarly with UDP-glucose. The signal of naringenin-7-O-β-D-glucosinolate corresponding to a mass-to-charge ratio of 433.1 before and after the glycosyltransferase reaction was detected, and the amount of newly generated glycoside was estimated using the difference in peak area before and after the reaction. Since the newly generated glycoside has the same parent ion mass as the original glycoside in the sample, the repeatability and matrix correction results of this difference were examined and compared with the independent isotope monitoring channel in Example 2.

[0076] Comparative Example 3: Simultaneous Hydrolysis Detection of Two Reaction Solutions Take peanut root extract from the same batch as in Example 2, mix thoroughly, and divide into equal volumes of control reaction solution D and mixed hydrolysis reaction solution E, 0.50 mL for each portion. Add 0.10 mL of acetate buffer without α-L-rhamnosidase and 0.10 mL of acetate buffer without β-D-glucosidase to control reaction solution D, respectively; add 0.10 mL of α-L-rhamnosidase solution and 0.10 mL of β-D-glucosidase solution to mixed hydrolysis reaction solution E simultaneously, so that the final concentration of both hydrolases in reaction solution E is 2.0 U / mL. Use acetate buffer with pH 5.0 to ensure that both reaction solutions have the same pH, ionic strength, and total volume of 0.70 mL, and react with shaking at 37°C for 105 min.

[0077] After the reaction was completed, reaction solutions D and E were immediately placed in an ice bath and transferred to an ultrafiltration module with a molecular weight cutoff of 10 kDa, respectively. The solutions were then centrifuged at 4°C and 12000 × g for 15 min. The filter membranes were washed with water, and the filtrates were combined. Both filtrates were then adjusted to the same pH, ionic strength, and final volume of 1.00 mL.

[0078] Take 0.20 mL each of reaction solution D and reaction solution E after condition adjustment, and add 0.20 mL of twice the concentration of glycosyltransferase reaction mixture to make the final reaction system contain 50 mmol / L Tris-HCl, 5 mmol / L MgCl2, and 1 mmol / L UDP-[U- 13 C6] Glucose and 0.1 mg / mL of the arachidonic transferase prepared in Example 1 were reacted at 30°C for 60 min. The reaction was then terminated by adding an equal volume of methanol. The mixture was centrifuged at 12000×g for 10 min, and the supernatant was collected for detection by liquid chromatography-tandem mass spectrometry.

[0079] Following the liquid chromatography and mass spectrometry conditions described in Example 2, with a mass-to-charge ratio of 439.1, naringenin-7-O-[U- 13 The parent ion of C6] glucosinolate was determined using a mass-to-charge ratio of 271.1 as the quantitative daughter ion. Based on a standard curve established using labeled glycoside references, the concentrations of naringenin-7-O-[U-] in reaction solutions D and E were obtained. 13 Determination of molar amount of C6] glucosinolate.

[0080] Test Example 1: Catalytic activity and substrate selectivity of arachidonic acid transferase The arachidonic transferase prepared in Example 1 was used to prepare a 200 μL reaction system containing 50 mmol / L Tris-HCl, 5 mmol / L MgCl2, 100 μmol / L acceptor substrate, 1 mmol / L glycosyl donor, and 0.1 mg / mL arachidonic transferase. The pH was 7.5, and the reaction was carried out at 30°C for 60 min. The reaction was terminated by adding an equal volume of methanol. Naringenin was used as the acceptor, and UDP-glucose or UDP-[U- 13 [C6] Glucose was used as the glycosyl donor. Liquid chromatography-tandem mass spectrometry was used to compare the retention time, secondary mass spectrometry fragmentation, and precise mass of the enzymatic product with the naringenin-7-O-β-D-glucoside standard. The results are shown in [Figure 1]. Figure 4 (A)- Figure 4 (C). In the kinetic assay, the concentrations of naringenin were set to 10 μmol / L, 20 μmol / L, 40 μmol / L, 60 μmol / L, 100 μmol / L, 150 μmol / L, 250 μmol / L, and 400 μmol / L, and the enzyme concentration was adjusted to 0.02 mg / mL. The reaction rate was determined during the initial linear reaction phase, and the Michaelis-Menten model was used to calculate the reaction rate. , The catalytic efficiency was also measured. Substrate conversion rates were determined under the same conditions using naringenin, glycyrrhizin, and hesperidin as acceptor substrates, respectively. Each group was prepared with three parallel reactions, and a control group without enzyme was included.

[0081] like Figure 4 As shown in (A), the retention times of the naringenin-7-O-β-D-glucoside standard and the enzymatic product were 4.823 min and 4.829 min, respectively, with a deviation of only 0.006 min. Figure 4 In (B), both samples showed major fragment ions with m / z values ​​of 271.06 and 151.00, and the cosine similarity of the fragment spectra was 0.998, proving that the enzyme-catalyzed product had the same structure as the standard. Figure 4 (C) Shows unlabeled product and [U- 13The precise mass-to-charge ratios of the C6-labeled products were 433.1135 and 439.1336, respectively, with a mass difference of 6.0201 Da, compared to 6... 13 The theoretical mass shift resulting from C atom substitution is consistent. Figure 4 In (D), K is used when using a common glycosyl donor and a labeled glycosyl donor. m The concentrations were 50.1 μmol / L and 50.9 μmol / L, respectively, k cat They are 0.220 s respectively. -1 and 0.205 s -1 The catalytic efficiencies were 4.40 × 10⁻⁶. 3 M -1 s -1 and 4.02×10 3 M -1 s -1 This indicates that stable isotope substitution did not significantly weaken the enzymatic reaction. Figure 4 In (E), the conversion rates of naringenin reached 92.4% and 89.1%, which were significantly higher than those of glycyrrhizin and hesperidin, indicating that the enzyme has a strong substrate preference for naringenin.

[0082] The above results indicate that the arachidonic transferase shown in SEQ ID NO:1 can selectively catalyze the formation of 7-O-glucoside from naringenin and can effectively utilize UDP-[U- 13 [C6] Glucose generates stable isotope-labeled products with independent mass channels. The technical effectiveness does not solely rely on liquid chromatography-tandem mass spectrometry itself, but rather utilizes the substrate selectivity of glycosyltransferases to convert the original or hydrolyzed naringenin into a single labeled product. Then, based on a mass shift of 6.0201 Da, the newly generated labeled product is distinguished from the original glycosides in the sample, thereby achieving product structure confirmation, signal source identification, and unified quantification of different forms of naringenin.

[0083] Test Example 2: Validation of the specificity and detection method of graded hydrolysis Quality control samples of free naringenin, naringenin-7-O-glucoside, and naringenin were prepared using a blank peanut root extract matrix, with six replicates for each group. The samples were divided into three treatments: Group A (no hydrolytic enzyme added); Group B (β-D-glucosidase added to 2.0 U / mL, reacted at 37℃ for 60 min); Group C (α-L-rhamnosidase added to 2.0 U / mL, reacted at 37℃ for 45 min, then β-D-glucosidase added to 2.0 U / mL, reacted for another 60 min). The samples were then processed according to the instructions. Figure 5 and Figure 6Sampling was performed at the indicated time points, and the relative contents of the substrate, intermediate, and naringenin were determined by LC-MS / MS. Following the calculation method described in Example 2, the overall recovery correction factor was determined based on the ratio of the increase in the molar amount of the labeled product before and after spiking to the molar amount of added free naringenin in treatments A, B, and C. , and Based on the release of naringenin from independently spiked samples of naringenin-7-O-β-D-glucoside and naringenin, the hydrolysis release rate was determined. and .

[0084] The hydrolysate was then passed through 3 kDa, 10 kDa, and 30 kDa ultrafiltration membranes, and centrifuged at 12000×g for 10 min at 4 °C. The recovery rate of naringenin and residual enzyme activity in the filtrate were compared. 0.2 mL of the filtrate was mixed with 0.2 mL of 2× labeled reaction solution to make the final system contain 50 mmol / L Tris-HCl, 5 mmol / L MgCl2, and 1 mmol / L UDP-[U- 13 C6] glucose and 0.1 mg / mL LOC112754776-encoded enzyme were reacted at pH 7.5 and 30℃ for 60 min, followed by LC-MS / MS detection. A 1 / x assay was established using 0.5–500 nmol / L labeled products. 2 The weighted calibration relationship was examined, and the limits of detection, limits of quantitation, low, medium and high level spiked recoveries, matrix effects of A / B / C treatments, intra-batch and inter-batch precision, stability after 24 h at 4°C and three freeze-thaw cycles, and consistency between known amounts and amounts calculated according to the formula were investigated.

[0085] like Figure 5 As shown, β-D-glucosidase treatment gradually decreased naringenin-7-O-glucoside levels over time, with the naringenin release rate reaching 94.8% at 60 min. Figure 6 As shown, naringin is first converted into a monoglucosidase intermediate during the action of α-L-rhamnosidase, and the intermediate reaches 87.2% at 45 min; after the addition of β-D-glucosidase, the intermediate gradually decreases, and the release rate of naringin reaches 93.6% at 105 min.

[0086] Figure 7(A) indicates that without the addition of hydrolytic enzymes, the release rates of naringenin from monoglucoside and naringin were only 2.3% and 1.1%, respectively; the addition of β-D-glucosidase alone increased the release rate of monoglucoside to 95.4%, while the release rate of naringin was only 3.2%; sequential dual-enzyme treatment increased the release rate of naringin to 93.6%. These results demonstrate that the three treatments (A, B, and C) in this test example can effectively distinguish between free, monoglucoside, and rutin-type naringenin. Furthermore, based on the molar amounts of labeled products before and after spiking in the three treatments (A, B, and C), the comprehensive recovery correction coefficient was determined according to the calculation formula described in Example 2. , and The values ​​were 0.986, 0.979, and 0.972, respectively. Based on the hydrolysis release results of the two independently spiked samples, the hydrolysis release rate of naringenin-7-O-β-D-glucoside was determined. The effective hydrolysis release rate of rutin in naringin was 0.954. The sum is 0.936.

[0087] like Figure 7 As shown in (B), when using 3 kDa, 10 kDa, and 30 kDa ultrafiltration membranes, the recovery rates of naringenin were 88.7%, 95.1%, and 96.4%, respectively, and the residual enzyme activity in the filtrate was 0.5%, 1.4%, and 3.7%, respectively. Although the 3 kDa membrane effectively removed the enzyme, there was some loss of the target analyte adsorption; the 30 kDa membrane had a higher recovery rate of the target analyte, but the residual enzyme activity was relatively increased. Considering both the recovery rate and the enzyme removal effect, the 10 kDa ultrafiltration membrane can be considered the preferred option.

[0088] like Figure 8 As shown in (A), the calibration equation for the labeled product in the range of 0.5–500 nmol / L is y = 1.842x + 0.061, R 2 =0.9999, the limit of detection and the limit of quantitation are 0.15 nmol / L and 0.50 nmol / L, respectively. Figure 8 (B) The recoveries of the three forms at low, medium, and high levels were 94.0%–102.3%; Figure 8 (C) The matrix effects of treatments A, B, and C ranged from -6.0% to 7.9%. Figure 8 (D) The intra-batch RSD was 2.3%–3.4%, and the inter-batch RSD was 4.2%–5.8%, both below 8%; the relative deviation of the samples after being placed at 4℃ for 24 h and after three freeze-thaw cycles did not exceed 6.5%. Figure 8 The combined fitting equation for the known input and calculated quantities shown in (E) is y = 0.989x + 0.367, R0 2 =0.9998.

[0089] The above results indicate that fractional hydrolysis produces incremental signals that can be distinguished from each other for the three naringenin forms. The ultrafiltration step suppresses interference from hydrolytic enzymes on subsequent labeling reactions, while stable isotope enzymatic labeling further corrects for matrix inhibition and instrument response fluctuations, thus enabling the separate determination of free, monoglucoside, and rutin-type naringenin in the same sample. Compared to methods that only measure total naringenin or only perform conventional external standard quantification, this application can simultaneously obtain content information for different bound forms, exhibiting better selectivity, accuracy, and resistance to matrix interference.

[0090] Test Example 3: Validation of the detection effect of stepwise hydrolysis combined with stable isotope enzymatic labeling Using the same batch of blank peanut root extract matrix, free naringenin, naringenin-7-O-β-D-glucoside, and naringenin were added to achieve aglycone molar equivalents of 5 nmol / L, 50 nmol / L, and 500 nmol / L, respectively, with six replicates at each level. The samples were randomly divided into four detection combinations: Combination I involved no fractional hydrolysis or isotope enzymatic labeling, and direct determination using liquid chromatography-tandem mass spectrometry; Combination II involved three-stage fractional hydrolysis (reaction solutions A, B, and C) followed by 10 kDa ultrafiltration to remove the enzyme, but without stable isotope enzymatic labeling, and the naringenin content in the three reaction solutions was directly determined using a matrix-matched standard curve with unlabeled naringenin. The three existing forms were calculated based on the results of reaction solution A, the difference between reaction solution B and A, and the difference between reaction solution C and B; Combination III involved no fractional hydrolysis, but only the conversion of free naringenin to naringenin-7-O-[U- 13 [C6] Glucosides, and natural glycosides, were calculated according to their respective mass spectrometry signals. Combination IV underwent three-stage fractional hydrolysis, 10 kDa ultrafiltration to remove the enzyme, and stable isotope enzymatic labeling. The three existing forms were calculated based on the correction results and differences of reaction solutions A, B, and C. All four combinations were tested using the same final volume, injection volume, and liquid chromatography-tandem mass spectrometry conditions. The overall quantitative error, cross-attribution rate of the three forms, spiked recovery rate, repeatability, and relative deviation between the theoretical amount added and the measured amount were compared.

[0091] The overall quantitative error is calculated according to the following formula: ; in, The combined quantitative error for the three existence forms; N is the number of detection results included in the calculation; For the first The concentration of each sample was determined; The theoretical concentration added for the corresponding sample.

[0092] like Figure 9As shown in (A), the combined quantitative errors of combinations I, II, III, and IV were 26.5%, 15.8%, 18.6%, and 4.3%, respectively. Stepwise hydrolysis alone reduced the error by 10.7 percentage points, and isotope enzymatic labeling alone reduced the error by 7.9 percentage points. Based on the error reduction rates of the two measures individually, the expected error after combining them was 7.9%, while the actual error of combination IV was 4.3%, a further reduction of 3.6 percentage points from the expected value. This result indicates that the sequential combination of stepwise hydrolysis and stable isotope enzymatic labeling significantly improves the quantitative error compared to using either measure individually.

[0093] Figure 9 (B) shows that the correct attribution rates of the four combinations to the three existing forms were 65.3%, 85.0%, 75.0%, and 96.7%, respectively, with corresponding cross-attribution rates of 34.7%, 15.0%, 25.0%, and 3.3%. Although combination II can distinguish the glycoside levels by using the determination results and differences of naringenin in the three reaction solutions A, B, and C, its detection results are more susceptible to the influence of the original free naringenin, matrix response, and differences in loss at each stage of treatment because it does not uniformly convert naringenin from different sources into labeled products with independent quality signals. Combination III can identify stable isotope-labeled products, but due to the lack of a stepwise hydrolysis release relationship, it cannot fully distinguish between monoglucosinolate and rutin glycoside states.

[0094] like Figure 9 (C) and as shown in Table 1, the average recoveries of combinations I to IV were 83.8%, 93.2%, 95.0%, and 99.1%, respectively, with corresponding coefficients of variation of 12.6%, 5.8%, 5.1%, and 2.4%. Combination IV had the closest recovery to 100% and the most concentrated distribution. Figure 9 As shown in (D), the median relative deviations of the four combinations were -16.9%, -5.9%, -3.5%, and -0.1%, respectively. The relative deviations of combination IV at the low, medium, and high addition levels were -4.5% to 4.7%, all within the ±10% range, indicating that the complete method did not show any significant concentration-dependent systematic bias at different concentration levels.

[0095] Table 2 Comparison of test results for different detection schemes in Test Example 3

[0096] The combination of primary and secondary fractional hydrolysis enables the conversion of different glycosylation levels into release signals identifiable by the incremental relationship between three different reaction solutions (A, B, and C), thus resolving the issue of source separation for free, monoglucosinolate, and rutin states. Meanwhile, stable isotope enzymatic labeling uniformly converts the naringenin released from each reaction solution into a single labeled product with a mass difference of 6.0201 Da, distinguishing between the original natural glycosides, the enzymatically produced new product, and the response differences arising from complex matrices. The former technique is a prerequisite for the latter—the labelable object after glycosylation hierarchically separated—while the latter unifies the response and source identification of the incremental signal formed in the previous step; they are interdependent in terms of detection sequence and signal formation mechanism.

[0097] Therefore, in this application, fractional hydrolysis, ultrafiltration to remove enzymes, stable isotope enzymatic labeling, and difference calculation are sequentially linked, so that naringenin in different bound forms is gradually released and measured separately, thereby reducing the mutual influence between different forms; at the same time, it can reduce the influence of different sample matrix or analyte concentrations on the detection results, and improve the accuracy and reliability of quantitative results.

[0098] Test Example 4: Phenotypic and Multi-omics Response of Peanut Roots under Salt and Exogenous Calcium Treatments In addition, peanut seeds with plump and uniform size were selected for an independent seedling dynamic treatment experiment. The seeds were soaked in distilled water and treated at a constant temperature. When the seeds germinated and the radicle length reached 1.5–3 times the hypocotyl length, they were transplanted into transparent plastic cups. Four groups were set up: a control group (CK), a Na group, a Ca group, and a Na_Ca group, with three biological replicates in each group. The CK group was treated with distilled water, the Na group with 150 mmol / L NaCl solution, the Ca group with 15 mmol / L CaCl2 solution, and the Na_Ca group with a mixed solution of 150 mmol / L NaCl and 15 mmol / L CaCl2. Phenotypic photographs of plants and roots were taken at 12 h, 24 h, 36 h, 48 h, 60 h, and 72 h after treatment. Roots were collected at 48 h to measure root length, root activity, malondialdehyde (MDA) content, soluble sugar content, total flavonoid content, DPPH free radical scavenging capacity, and ABTS free radical scavenging capacity. Root length was expressed as the length from the base of the main root to the root tip, in cm. Root activity was determined using the TTC reduction method, expressed as the amount of triphenylformaldehyde generated per unit fresh weight of root per unit time, in μg TTF / (g FW·h). MDA content was determined using the thiobarbituric acid colorimetric method, in nmol / g FW. Soluble sugar content was determined using the anthrone colorimetric method, in mg / g FW. Total flavonoid content was expressed as the flavonoid content per unit fresh weight of root, in μg / g FW. DPPH and ABTS free radical scavenging capacities were expressed as scavenging rates, in %. Data from the quantitative metabolomics, broad-target metabolomics, and transcriptomics of flavonoids, corresponding to the treatment groups in this test case, were selected. Principal component analysis, differential metabolite clustering, and KEGG pathway enrichment analysis were performed to assist in the analysis of flavonoid metabolic responses in peanut roots under salt and exogenous calcium treatments. Results at 48 h are expressed as mean ± sample standard deviation.

[0099] Table 3. Growth and physiological indicators of each treatment group in Test Example 4 after 48 hours (n=3)

[0100] Note: In Table 3, FW represents fresh weight; TTF represents triphenylformazan, which is the colored product formed after TTC is reduced by root dehydrogenase.

[0101] Table 4. Results of antioxidant index detection in each treatment group of Test Example 4 from 12h to 72h.

[0102] The process of soaking, germinating and transplanting peanut seeds is as follows: Figure 10 and Figure 11 As shown; the plant and root phenotypes after 12–36 h and 48–72 h of treatment are respectively as follows. Figure 12 and Figure 13 As shown, observable differences were observed between the different treatment groups in terms of root elongation, growth status, and degree of recovery after treatment.

[0103] Figure 10 (A) and Figure 10 (B) The constant temperature soaking state of peanut seeds was recorded from different angles. The selected seeds fully absorbed water in the soaking solution and were evenly distributed, which is conducive to keeping the water absorption degree and germination point of each seed consistent. Figure 11 (A) indicates that after soaking and germination, most seeds have absorbed water, swelled, and begun to show their radicles; Figure 11 (B) is the initial state of the germinating seeds after they have been transferred into the culture container (transparent plastic cup). At this time, the radicle has formed, but the root system has not yet fully developed. Figure 11 (C) The diagram shows that the taproot continues to elongate and gradually forms lateral roots; Figure 11 (D) shows the seedling state before the formal treatment begins. The root systems of the seedlings in each group have been initially established, and their overall growth is relatively similar. By soaking seeds, germinating seeds, transplanting, and screening before treatment, the impact of differences in seed germination degree and initial seedling state on subsequent test results can be reduced.

[0104] Peanut seedlings were photographed at different treatment times to observe their growth. Figure 12 and Figure 13 Each subplot, from left to right, represents: control group; NaCl treatment group; CaCl2 treatment group; and combined NaCl and CaCl2 treatment group. Figure 12 (A) is a photo taken at 12 hours after treatment. At this stage, the overall growth of seedlings in each group is relatively similar, and the differences between root systems are not significant, mainly reflecting the initial response of seedlings after different treatments. When the treatment reaches 24 hours, according to Figure 12 (B) It can be seen that root elongation in the NaCl-treated group was somewhat restricted, but the combined treatment group still had a certain ability to extend roots. After 36 hours of treatment, according to Figure 12 (C) It can be found that the differences in seedling growth among the groups are more significant. The root development of the NaCl treatment group is relatively slow, but the CaCl2 treatment group and the combined treatment group both show good root integrity and good seedling growth.

[0105] As processing time increased, the phenotypic differences between groups became increasingly clear. Figure 13 middle, Figure 13(A) The seedlings were in their final state after 48 hours of treatment. At this time, root elongation and plant growth were significantly inhibited in the NaCl-treated group, while the combined treatment group showed some recovery compared to the NaCl-treated group. This is consistent with the data on root length, root activity, malondialdehyde content, and total flavonoid content measured at this period. When the treatment time was 60 hours, as... Figure 13 As shown in (B), the growth lag still exists in the NaCl-treated group, while the combined treatment group can still maintain relatively good root and aboveground growth; as Figure 13 As shown in (C), after 72 hours of treatment, the control group and the CaCl2 treatment group showed good overall growth, while the NaCl treatment group showed a more significant degree of inhibition. The combined treatment group showed better root and plant growth than the NaCl treatment group, but not yet reached the level of the control group. These experimental results indicate that the inhibitory effect of salt stress on peanut seedling root growth gradually becomes apparent over time. Exogenous calcium can alleviate root damage under continuous salt stress and provides phenotypic evidence for further research on the different forms of flavonoids and naringenin in peanut roots.

[0106] Table 2 shows that after 48 h of treatment, the root length and root activity in the Na group were 11.99±1.68 and 40.89±5.08, respectively, which were lower than those in the CK group (16.54±4.10 and 114.16±15.59). The malondialdehyde (MDA) content in the Na group was 12.82±1.42, which was higher than that in the CK group (5.18±0.62), indicating that salt treatment inhibited root growth and caused membrane lipid peroxidation. Compared with the Na group, the root length in the Na-Ca group increased to 15.30±0.96, the root activity increased to 80.19±7.98, and the MDA content decreased to 9.88±1.56, representing increases of 27.6%, 96.1%, and a decrease of 22.9%, respectively. This indicates that co-treatment with CaCl2 can alleviate root damage caused by NaCl treatment.

[0107] The total flavonoid content in the Na_Ca group at 48 h was 85.84±6.81 μg / g, higher than that in the Na group (76.00±5.45 μg / g). The DPPH free radical scavenging capacity increased from 25.15±1.89% in the Na group to 33.94±3.19%, and the ABTS free radical scavenging capacity increased from 65.14±2.66% to 66.08±4.20%. Time-series data from 12 to 72 h also showed that the DPPH and ABTS responses of different treatment groups changed with treatment time. For example, at 36 h, the DPPH value in the Na_Ca group was 31.30, higher than that in the Na group (19.13), indicating that the antioxidant response produced by the combined treatment was not a single endpoint difference but rather time-dependent.

[0108] PCA results of flavonoid quantitative metabolomics group are as follows Figure 14As shown, PC1 and PC2 explained 60.67% and 14.40% of the sample differences, respectively. The CK, Na, Ca, and Na_Ca groups showed overall separation in the two-dimensional score space. It should be noted that... Figure 14 In the table, CK1, CK2, and CK3 represent three biological replicates of the control group; Na1, Na2, and Na3 represent three biological replicates of the salt stress group; Ca1, Ca2, and Ca3 represent three biological replicates of the exogenous calcium treatment group; and Na_Ca1, Na_Ca2, and Na_Ca3 represent three biological replicates of the combined salt stress and exogenous calcium treatment group. MWXS22307a_R1, MWXS22307a_R2, and MWXS22307a_R3 are quality control sample numbers, belonging to the experimental sample codes. The broad-target metabolomics K-Means results are as follows: Figure 15 As shown, the 635 differentially expressed metabolites were divided into 6 response trajectories, with each category containing 98, 50, 44, 40, 302, and 101 metabolites, respectively, indicating that the metabolic responses induced by different treatments have significant class differences. Figure 16 The transcriptome KEGG enrichment results show pathways including flavonoid biosynthesis, isoflavone biosynthesis, and secondary metabolite biosynthesis. Clustering results of flavonoid metabolites in peanut roots from different treatment groups are shown below. Figure 17 As shown in the figure, the CK, Na, Ca, and Na_Ca groups each include three biological replicates. The color distribution of samples within each group is generally similar, while there are significant differences in abundance distribution between different treatment groups. Figure 14 The principal component analysis results shown corroborate each other. Compared to the CK group, the Na group exhibited relatively high abundance of many flavonoid metabolites, indicating that salt stress elicited a broad response in peanut root flavonoid metabolism. The Ca group showed a different metabolic distribution than the Na group, and the Na-Ca group did not simply replicate the patterns of the Na or Ca groups. The relative abundance of some metabolites increased, while that of others decreased, indicating that exogenous calcium can regulate flavonoid metabolism under salt stress.

[0109] Figure 17 It also indicates that the substances involved in the response include multiple categories such as flavonoids, isoflavones, flavonols, flavanones, chalcones, flavanols, and flavonoid glycosides, suggesting that the changes caused by different treatments are not merely a general increase or decrease in total flavonoid content, but rather include differential changes in different flavonoid structures and glycosylation forms. Conventional total flavonoid detection or comparison of peak areas of single metabolites is insufficient to further determine whether the naringenin signal originates from the free form, monoglucoside form, or rutin glycoside form. This application uses fractional hydrolysis to sequentially release naringenin in different bound forms, and utilizes peanut flavonoid glycosyltransferase to convert the released naringenin into a stable isotope-labeled product with an independent mass signal, enabling quantification of the three existing forms separately. Therefore, Figure 17The necessity of conducting morphological differentiation detection is explained from the perspective of metabolic differences in real peanut roots, and it demonstrates that this application has a clearer source identification ability and a more detailed quantitative resolution compared to methods that only measure total flavonoids or directly detect natural glycosides.

[0110] The above results indicate that different salt and exogenous calcium treatments can produce peanut root samples with varying growth states and physiological indicators, accompanied by responses in flavonoid metabolites and related synthetic pathways. Total flavonoids and omics analysis can reflect the overall changes in flavonoid metabolism in peanut roots, but cannot directly distinguish the individual contents of free naringenin, naringenin-7-O-β-D-glucoside, and naringenin. Therefore, these results provide a sample basis and application evidence for further analysis of different forms of naringenin in real peanut root samples using the methods described in this application.

[0111] Although the present invention has been described in detail above with general descriptions and specific embodiments, modifications or improvements can be made to it, which will be obvious to those skilled in the art. Therefore, all such modifications or improvements made without departing from the spirit of the present invention fall within the scope of protection claimed by the present invention.

Claims

1. A peanut flavonoid glycosyltransferase, characterized in that, The amino acid sequence of the peanut flavonoid glycosyltransferase is shown in SEQ ID NO:1, and is in the form of UDP-glucose or UDP-[U- 13 [C6] Glucose is used as a glycosyl donor, and the glucose or [U- 13 [C6] Glucose is transferred to the 7-hydroxyl group of naringenin.

2. A polynucleotide encoding peanut flavonoid glycosyltransferase, characterized in that, The nucleotide sequence of the polynucleotide is shown in SEQ ID NO:2, which encodes a peanut flavonoid glycosyltransferase capable of transferring glucose or [U- 13 Catalytic activity of C6] glucose transfer to the 7-hydroxyl group of naringenin.

3. A method for preparing the peanut flavonoid glycosyltransferase according to claim 1, characterized in that, The recombinant expression vector containing the nucleotide sequence shown in SEQ ID NO:2 is introduced into host cells, the host cells are cultured and expression is induced, the cells or cultures are collected, purified by affinity chromatography, and optionally further purified by molecular sieve chromatography.

4. A method for detecting naringenin, naringenin-7-O-β-D-glucoside, and naringenin in peanut root samples, characterized in that, include: Peanut root extract was divided into three equal portions: reaction solution A, reaction solution B, and reaction solution C. Reaction solution A was not hydrolyzed; reaction solution B was hydrolyzed using β-D-glucosidase; and reaction solution C was hydrolyzed sequentially using α-L-rhamnosidase and β-D-glucosidase. After terminating hydrolysis and removing the hydrolytic enzymes, the three reaction solutions were adjusted to the same reaction conditions, and arachidonic acid transferase (as shown in SEQ ID NO:1) and UDP-[U-] were added to each. 13 C6] glucose, which converts naringenin in it into naringenin-7-O-[U- 13 C6] Glucoside; The amount of the labeled glycoside in the three reaction solutions was determined by liquid chromatography-tandem mass spectrometry. Based on the determination results of reaction solution A, the correction difference between reaction solution B and reaction solution A, and the correction difference between reaction solution C and reaction solution B, the contents of free naringenin, naringenin-7-O-β-D-glucoside and naringenin were determined respectively.

5. The detection method according to claim 4, characterized in that, In reaction solution B, β-D-glucosidase hydrolyzes naringenin-7-O-β-D-glucosinolate to release naringenin; in reaction solution C, α-L-rhamnosidase first hydrolyzes naringenin to naringenin-7-O-β-D-glucosinolate, and then β-D-glucosidase hydrolyzes it to release naringenin; after hydrolysis, the hydrolytic enzymes are removed using an ultrafiltration membrane with a molecular weight cutoff of 3 kDa to 30 kDa, the ultrafiltrate is collected, and the pH, ionic strength, and volume of reaction solutions A, B, and C are adjusted to ensure that the three reaction solutions have the same enzymatic reaction conditions before the addition of the peanut flavonoid glycosyltransferase.

6. The detection method according to claim 4, characterized in that, Naringenin-7-O-[U- 13 [C6] glucoside has a molecular weight difference of 6.0201 Da compared to naringenin-7-O-β-D-glucoside; using naringenin-7-O-β-D-glucoside and naringenin-7-O-[U- 13 At least one of the C6 glucosides is used as a quantitative reference, and the labeled glycoside is identified based on at least two of the chromatographic retention time, the mass of the parent ion, and the mass of the daughter ion.

7. The detection method according to claim 4, characterized in that, The aglycone molar equivalent of free naringenin was obtained by the following method: Naringenin-7-O-[U- 13 The molar amount of C6] glucosinolate was divided by the comprehensive recovery correction coefficient of reaction solution A, and then divided by the mass of peanut root sample. The aglycone molar equivalent of naringenin-7-O-β-D-glucoside was obtained by dividing the measured molar amount of the labeled glycoside in reaction solution B and reaction solution A by the corresponding comprehensive recovery correction coefficient, subtracting the corrected molar amount of reaction solution A from the corrected molar amount of reaction solution B, and then dividing the difference by the hydrolysis release rate of naringenin-7-O-β-D-glucoside and the sample mass. The molar equivalent of naringin was obtained by dividing the measured molar amount of the labeled glycoside in reaction solution C and reaction solution B by the corresponding comprehensive recovery correction coefficient, subtracting the corrected molar amount of reaction solution B from the corrected molar amount of reaction solution C, and then dividing the difference by the hydrolysis release rate of naringin and the sample mass.

8. A kit for detecting the speciation of flavonoids in peanut root samples, characterized in that, Including arachidonic transferase with an amino acid sequence as shown in SEQ ID NO:1, UDP-[U- 13 [C6] Glucose, β-D-glucosidase, α-L-rhamnosidase, glycosyltransferase reaction buffer and hydrolysis reaction buffer.

9. The detection kit according to claim 8, characterized in that, It also includes naringenin, naringenin-7-O-β-D-glucoside, naringenin and naringenin-7-O-[U- 13 The C6] glucosidase contains at least one quantitative reference, and an ultrafiltration unit with a molecular weight cutoff of 3kDa to 30kDa; the β-D-glucosidase and α-L-rhamnosidase are packaged separately.

10. The application of the arachidonic transferase with the amino acid sequence shown in SEQ ID NO:1 in the preparation of a detection reagent or kit for distinguishing and detecting free naringenin, naringenin-7-O-β-D-glucoside, and naringenin in peanut root samples, wherein, Arachidonic acid transferase in the form of UDP-[U- 13 [C6] Glucose serves as a sugar donor, converting naringenin, either pre-existing or released during hydrolysis, into naringenin-7-O-[U-] 13 C6] glucoside.